Literature DB >> 21873497

Impaired cardiac reserve and severely diminished skeletal muscle O₂ utilization mediate exercise intolerance in Barth syndrome.

Carolyn T Spencer1, Barry J Byrne, Randall M Bryant, Renee Margossian, Melissa Maisenbacher, Petar Breitenger, Paul B Benni, Sharon Redfearn, Edward Marcus, W Todd Cade.   

Abstract

Barth syndrome (BTHS) is a mitochondrial myopathy characterized by reports of exercise intolerance. We sought to determine if 1) BTHS leads to abnormalities of skeletal muscle O(2) extraction/utilization and 2) exercise intolerance in BTHS is related to impaired O(2) extraction/utilization, impaired cardiac function, or both. Participants with BTHS (age: 17 ± 5 yr, n = 15) and control participants (age: 13 ± 4 yr, n = 9) underwent graded exercise testing on a cycle ergometer with continuous ECG and metabolic measurements. Echocardiography was performed at rest and at peak exercise. Near-infrared spectroscopy of the vastus lateralis muscle was continuously recorded for measurements of skeletal muscle O(2) extraction. Adjusting for age, peak O(2) consumption (16.5 ± 4.0 vs. 39.5 ± 12.3 ml·kg(-1)·min(-1), P < 0.001) and peak work rate (58 ± 19 vs. 166 ± 60 W, P < 0.001) were significantly lower in BTHS than control participants. The percent increase from rest to peak exercise in ejection fraction (BTHS: 3 ± 10 vs. control: 19 ± 4%, P < 0.01) was blunted in BTHS compared with control participants. The muscle tissue O(2) saturation change from rest to peak exercise was paradoxically opposite (BTHS: 8 ± 16 vs. control: -5 ± 9, P < 0.01), and the deoxyhemoglobin change was blunted (BTHS: 0 ± 12 vs. control: 10 ± 8, P < 0.09) in BTHS compared with control participants, indicating impaired skeletal muscle extraction in BTHS. In conclusion, severe exercise intolerance in BTHS is due to both cardiac and skeletal muscle impairments that are consistent with cardiac and skeletal mitochondrial myopathy. These findings provide further insight to the pathophysiology of BTHS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873497     DOI: 10.1152/ajpheart.00479.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  42 in total

1.  Reduced Muscle Strength in Barth Syndrome May Be Improved by Resistance Exercise Training: A Pilot Study.

Authors:  Adam J Bittel; Kathryn L Bohnert; Dominic N Reeds; Linda R Peterson; Lisa de Las Fuentes; Manuela Corti; Carolyn L Taylor; Barry J Byrne; W Todd Cade
Journal:  JIMD Rep       Date:  2018-04-14

2.  Blunted fat oxidation upon submaximal exercise is partially compensated by enhanced glucose metabolism in children, adolescents, and young adults with Barth syndrome.

Authors:  William Todd Cade; Kathryn L Bohnert; Linda R Peterson; Bruce W Patterson; Adam J Bittel; Adewole L Okunade; Lisa de Las Fuentes; Karen Steger-May; Adil Bashir; George G Schweitzer; Shaji K Chacko; Ronald J Wanders; Christina A Pacak; Barry J Byrne; Dominic N Reeds
Journal:  J Inherit Metab Dis       Date:  2019-04-11       Impact factor: 4.982

Review 3.  Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.

Authors:  Nikita Ikon; Robert O Ryan
Journal:  Lipids       Date:  2017-01-09       Impact factor: 1.880

Review 4.  Metabolic biology of 3-methylglutaconic acid-uria: a new perspective.

Authors:  Betty Su; Robert O Ryan
Journal:  J Inherit Metab Dis       Date:  2014-01-10       Impact factor: 4.982

Review 5.  The functions of cardiolipin in cellular metabolism-potential modifiers of the Barth syndrome phenotype.

Authors:  Vaishnavi Raja; Miriam L Greenberg
Journal:  Chem Phys Lipids       Date:  2014-01-17       Impact factor: 3.329

Review 6.  Reign in the membrane: How common lipids govern mitochondrial function.

Authors:  Katsuhiko Funai; Scott A Summers; Jared Rutter
Journal:  Curr Opin Cell Biol       Date:  2020-02-24       Impact factor: 8.382

Review 7.  TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome.

Authors:  Anders O Garlid; Calvin T Schaffer; Jaewoo Kim; Hirsh Bhatt; Vladimir Guevara-Gonzalez; Peipei Ping
Journal:  Gene       Date:  2019-10-21       Impact factor: 3.688

8.  Cerebral Oxygen Saturation in Children With Congenital Heart Disease and Chronic Hypoxemia.

Authors:  Barry D Kussman; Peter C Laussen; Paul B Benni; Francis X McGowan; Doff B McElhinney
Journal:  Anesth Analg       Date:  2017-07       Impact factor: 5.108

9.  Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.

Authors:  Paul Hsu; Xiaolei Liu; Jun Zhang; Hong-Gang Wang; Ji-Ming Ye; Yuguang Shi
Journal:  Autophagy       Date:  2015-04-03       Impact factor: 16.016

10.  AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome.

Authors:  Silveli Suzuki-Hatano; Madhurima Saha; Skylar A Rizzo; Rachael L Witko; Bennett J Gosiker; Manashwi Ramanathan; Meghan S Soustek; Michael D Jones; Peter B Kang; Barry J Byrne; W Todd Cade; Christina A Pacak
Journal:  Hum Gene Ther       Date:  2018-10-03       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.